Chances are that you or someone you know has been directly impacted by breast cancer. With 2,088,849 new cases and 626,679 deaths globally,1 it is the most frequently diagnosed cancer in women in most countries… Read more >
You can configure each Validation Protocol method to enforce Approval requirements, Sign off requirements, or both, during various stages of your Method Validation workflow. In this week’s tip, we will continue our discussion on Validation Protocols and learn how to set up Approvals and Sign offs.
At Waters there is a fundamental ethic in the company around doing the right thing to help customers, fellow employees and the world by advancing science to enhance human health and well-being. Everything we do… Read more >
In this series, we review considerations for keeping your lab at the forefront of science. As we adjust to living and working in a pandemic and anticipate future global and geopolitical events, Waters remains dedicated… Read more >
Many years ago, I was hired by a biopharma company to develop analytical methods for therapeutic oligonucleotides. When a new colleague warned me about sample loss on LC columns I looked at him with skepticism.… Read more >
In our current series on Validation Protocols, we reviewed Validation Tests that determined whether the ‘chromatographic method’ is valid. In this tip, we’ll discuss a Validation Test that determines whether the ‘chromatographic system’ is valid.
In this week’s tip, we will continue our discussion on configuring tests for the Validation Protocol and learn how to set up the Accuracy Test.
Since the early 2000s and the advent of the first guidance relating to mutagenic impurities developed by the European Medicines Agency (EMA), it has been necessary to assess the risk posed by mutagenic impurities. Although… Read more >
In this week’s Empower tip, we will continue our discussion on Validation Protocols and learn how to set up the Repeatability Test.
On September 1, 2020, Udit Batra became Waters’ President and CEO. Udit brings a wealth of knowledge and experience to Waters, having previously held executive positions at Novartis and Merck KGaA. Most recently, he served… Read more >
